Service de Gynécologie Obstétrique - CHU Saint-Etienne
Saint-Etienne, 42055, France
NCT Number: NCT00767182
Pregnancy complications called PVP are mainly responsible for perinatal mortality. In these cases, the placenta is smaller and often the centre of thrombotic lesions. The estimation of the placenta volume by 3D ultrasound coupled with growth factors and D-Dimers measures could improve the understanding of these pathologies to optimize their detection.
Looking for future studies?
Notify Me18 year–50 year
Female
Observational
Saint-Etienne, 42055, France
Pregnancy complications called Placental Vascular Pathologies (PVP) are mainly responsible for perinatal mortality. In these cases, the placenta is smaller and often the centre of thrombotic lesions. The estimation of the placenta volume by 3D ultrasound coupled with growth factors and D-Dimers measures could improve the understanding of these pathologies to optimize their detection. Thus, the identification of predictive factors of the risk of occurrence or recurrence of PVP could allow us to propose a monitoring of patients at risk, to anticipate corticoids administration for the foetuses pulmonary maturation and perhaps later to adapt anti hypertensive and antithrombotic therapeutics.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
biological markers evaluated : D-Dimer, sEPCR
Time frame: Week 12
Time frame: Week 12
Time frame: Week 16
Time frame: Week 22
Time frame: Week 12
Time frame: Week 16
Time frame: Week 22
Time frame: Week 16
Time frame: Week 22
Centre Hospitalier Universitaire de Saint Etienne
Other
Estimation of the Placental Volume by 3D Ultrasound at 12, 16 and 22 Weeks : Relation With Growth Factors and D-Dimers - Monocentric Prospective Cohort
Acronym: VOLUPLA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07646561
Eclampsia, Female Urogenital Diseases and Pregnancy Complications
Tunis, Tunisia
View Trial DetailsNCT06069102
Cardiovascular Diseases, Eclampsia
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT01736826
Cardiovascular Diseases, Death
Nîmes, France
View Trial DetailsNCT06054841
Cardiovascular Diseases, Cervical Dysplasia
Washington D.C., District of Columbia, United States
View Trial Details